My husband was diagnosed with Stage IV metastatic prostate cancer in September 2006 with a PSA of 3400! Treatment with Eligard broght PSA to .7. However, at 18 months PSA began to climb again.. Adding Casodex helped stabilize PSA for another 6-7 months. When that failed he began ketaconazole which helped for another 8-9 months. He is now consider hormone refractory. He began taxotere with prednisone 5 weeks ago. At 3 weeks his PSA had not dropped, but in fact had risen from 18 to 29. Complicating all this, about 15 months ago he suffered a severe bout of bacteremia which left him with a vegetation on his pulmonic valve. The fear of chemo was that the bacteremia would recur. This morning he is suffering chills and rigors, a clear indication that the bacteremia has recurred. What options are left?

Obviously, your husband is very ill and his management will be very complex and challenging. In this case, I can only make some suggestions that you might consider. Leukine is a human hormone that increases immune system functioning. By itself, it can slow the growth of prostate cancer. However, Eric Small at UCSF reported a 70% response rate to Leukine combined with Ketoconazole in patients who have failed Lupron and Casodex. In my experience, Dr. Small's estimate of the response rate is right on the money. Additionally, I have found this combination even works when ketoconazole has previously failed. The fact that Leukine increases immune response seems a particularly advantage, given your husband's infection. There are some issues to consider. Ketoconazole must be given every 8 hours by the clock. It needs to be taken with an acid beverage like soda or fruit juice, but not grape fruit juice. Vitamin C, 500 mg, can be used instead to acidify his stomach. Ketoconazole interferes with the body's disposal of half of all prescription drugs. This includes several widely used antibiotics. Your physicians will need to consult available databases before placing you on any antibiotics while on ketoconazole.

Ask Dr. Espinosa

Geo Espinosa, N.D., L.Ac, CNS, RH (AHG) is the Director of the Integrative Urological Center at New York University Langone Medical Center. Before joining NYU, Dr. Espinosa was a clinician, researcher and director of clinical trials at the Center for Holistic Urology at Columbia University Medical Center. He is a licensed naturopathic doctor, licensed acupuncturist, a Certified Nutrition Specialist and a Registered Herbalist. Dr. Espinosa is an author of the naturopathic entry in 1000 Cures for 200 ailments, by Harper Collins; March 2007 and “Prostate cancer – Nutrients that may slow its progression,” Food and Nutrients in Disease Management - Maryland: Cadmus Publishing, 2009.

Ask Dr. Myers

Medical oncologist and prostate cancer survivor, Dr Charles "Snuffy" Myers was a key player in creating AZT, Suranim, and Phenylacetate while working at the National Institute of Health. With over 250 research papers published, Myers is one of the leading developers of today's prostate cancer canon on both the research and treatment side of the test tube. Former Cancer Director at the University of Virginia, Myers opened the American Institute for Diseases of the Prostate in 2002 to provide men with the kind of comprehensive care that saved his own life. Dr. Myers has long been popular among prostate cancer patients as a speaker because of his ability to explain science and medicine in easy-to-understand language.

Ask Dr. Latini

Dr. Latini welcomes your questions about the psycho-social dimensions of Prostate Cancer, particularly those presented by Gay and Bisexual men. Dr. Latini is an assistant professor of urology at Baylor College of Medicine. Before joining Baylor, he spent six years in the Department of Urology at the University of California, San Francisco. Dr. Latini is a clinical health psychologist whose work concentrates on cancer survivorship and symptom management for persons living with genitourinary cancer.